| 000 | 01543 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513204651.0 | ||
| 264 | 0 | _c20000525 | |
| 008 | 200005s 0 0 fre d | ||
| 022 | _a1246-7820 | ||
| 024 | 7 |
_a10.1016/s1246-7820(00)88709-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHervé, P | |
| 245 | 0 | 0 |
_a[Transfusion safety: emergent or hypothetical risks]. _h[electronic resource] |
| 260 |
_bTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _cFeb 2000 |
||
| 300 |
_a30-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Donors |
| 650 | 0 | 4 |
_aBlood Transfusion _xstandards |
| 650 | 0 | 4 |
_aCreutzfeldt-Jakob Syndrome _xblood |
| 650 | 0 | 4 |
_aEncephalopathy, Bovine Spongiform _xtransmission |
| 650 | 0 | 4 |
_aFlaviviridae _xisolation & purification |
| 650 | 0 | 4 |
_aHepatitis Viruses _xclassification |
| 650 | 0 | 4 |
_aHepatitis, Viral, Human _xblood |
| 650 | 0 | 4 |
_aHerpesviridae Infections _xblood |
| 650 | 0 | 4 | _aHerpesvirus 8, Human |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 650 | 0 | 4 | _aTravel |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 773 | 0 |
_tTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _gvol. 7 _gno. 1 _gp. 30-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1246-7820(00)88709-1 _zAvailable from publisher's website |
| 999 |
_c10683887 _d10683887 |
||